Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

Adv Pharm Bull. 2023;13(1): 113-122. doi: 10.34172/apb.2023.012

PMID: 36721815 PMCID: PMC9871275

Research Article

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

Ali Akbar Alizadeh ^1,2 , Behzad Jafari ³, Siavoush Dastmalchi ^1,4 *

Cited by CrossRef: 2

1- Asadi P, Khodarahmi G, Rafiee A, Aliomrani M, Hassanzadeh F. Design, Synthesis, Bioactivity Analyses, and Molecular Docking Study of Triazine-Tyrosine Based Derivatives as Drugs like Fingolimod for Treatment of Multiple Sclerosis. Polycyclic Aromatic Compounds. 2024;44(4):2292 [Crossref]

2- Fajriaty I, Fidrianny I, Kurniati N, Fauzi N, Mustafa S, Adnyana I. In vitro and in silico studies of the potential cytotoxic, antioxidant, and HMG CoA reductase inhibitory effects of chitin from Indonesia mangrove crab (Scylla serrata) shells. Saudi Journal of Biological Sciences. 2024;31(5):103964 [Crossref]